These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36971921)

  • 1. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
    Li L; Ni R; Zheng D; Chen L
    Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can nanomedicines kill cancer stem cells?
    Zhao Y; Alakhova DY; Kabanov AV
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
    Zhang Z; Deng Q; Xiao C; Li Z; Yang X
    Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
    Malhi S; Gu X
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells.
    Oswald JT; Patel H; Khan D; Jeorje NN; Golzar H; Oswald EL; Tang S
    Curr Pharm Des; 2020; 26(17):2057-2071. PubMed ID: 32250211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
    Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
    World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
    Singh VK; Saini A; Chandra R
    Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
    Chen K; Huang YH; Chen JL
    Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells and drug resistance: the potential of nanomedicine.
    Vinogradov S; Wei X
    Nanomedicine (Lond); 2012 Apr; 7(4):597-615. PubMed ID: 22471722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming Cancer Stem-like Cells with Nanoforskolin Enhances the Efficacy of Paclitaxel in Targeting Breast Cancer.
    Singh D; Singh P; Pradhan A; Srivastava R; Sahoo SK
    ACS Appl Bio Mater; 2021 Apr; 4(4):3670-3685. PubMed ID: 35014452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells and strategies for targeted drug delivery.
    Cao J; Bhatnagar S; Wang J; Qi X; Prabha S; Panyam J
    Drug Deliv Transl Res; 2021 Oct; 11(5):1779-1805. PubMed ID: 33095384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cells and their Management in Cancer Therapy.
    Shenouda S; Kulkarni K; Abuetabh Y; Sergi C
    Recent Pat Anticancer Drug Discov; 2020; 15(3):212-227. PubMed ID: 32660407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering cancer stem cell therapies - a role for nanomedicines?
    Schätzlein AG
    Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.